Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes

Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of general psychiatry 2004-12, Vol.61 (12), p.1271-1279
Hauptverfasser: MEYER, Jeffrey H, HOULE, Sylvain, SAGRATI, Sandra, CARELLA, Anna, HUSSEY, Doug F, GINOVART, Nathalie, GOULDING, Verdell, KENNEDY, James, WILSON, Alan A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1279
container_issue 12
container_start_page 1271
container_title Archives of general psychiatry
container_volume 61
creator MEYER, Jeffrey H
HOULE, Sylvain
SAGRATI, Sandra
CARELLA, Anna
HUSSEY, Doug F
GINOVART, Nathalie
GOULDING, Verdell
KENNEDY, James
WILSON, Alan A
description Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin. Regional 5-HTT BP was measured in 20 nonsmoking medication-free (> or =3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale. No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F(1,26), 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to
doi_str_mv 10.1001/archpsyc.61.12.1271
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67148800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67148800</sourcerecordid><originalsourceid>FETCH-LOGICAL-p154t-ac8e2b0fe0169bc74c5fcda0aa8edec37c57ce04167de99650206decccccd2103</originalsourceid><addsrcrecordid>eNpF0MFu1DAQAFALgehS-AIk5Au9ZfHEiZNwa0uBSpV6aJG4rSb2pOsqsYPttMrH8W94xSIsSx57nkbjYew9iC0IAZ8w6P0cV71VsIUy7wZesA3Usi2kkuol2wghZNF14ucJexPjY76KWpWv2QnUdSsB2g37fRHQOn5HwSfvcpQCujj7kCjw3jpj3QOffSKXLI58IoxLIMOfbdpzjaH3jgMUI_Y05ucv53cXmUebQk7QZGO0OUh-8g8B5_36mV8NA-kUuR_4hI8-cENzoOyeiNNsozcUOTrDIz1RsGk9SLPGYXE65WK5C0zJpiW7t-zVgGOkd8fzlP34enV_-b24uf12fXl-U8xQV6lA3VLZi4EEqK7XTaXrQRsUiC0Z0rLRdaNJVKAaQ12nalEKlROHZUoQ8pSd_a07B_9roZh2-WeaxhEd-SXuVANV24oD_HCESz-R2c3BThjW3b-BZ_DxCDBqHIc8bW3jf6dkVVVQyj9CmJh3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67148800</pqid></control><display><type>article</type><title>Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>MEYER, Jeffrey H ; HOULE, Sylvain ; SAGRATI, Sandra ; CARELLA, Anna ; HUSSEY, Doug F ; GINOVART, Nathalie ; GOULDING, Verdell ; KENNEDY, James ; WILSON, Alan A</creator><creatorcontrib>MEYER, Jeffrey H ; HOULE, Sylvain ; SAGRATI, Sandra ; CARELLA, Anna ; HUSSEY, Doug F ; GINOVART, Nathalie ; GOULDING, Verdell ; KENNEDY, James ; WILSON, Alan A</creatorcontrib><description>Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin. Regional 5-HTT BP was measured in 20 nonsmoking medication-free (&gt; or =3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale. No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F(1,26), 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to &lt;.001]). Serotonin transporters play an important role during depression. The magnitude of regional 5-HTT BP can provide a vulnerability to low levels of extracellular serotonin and symptoms of extremely negativistic dysfunctional attitudes.</description><identifier>ISSN: 0003-990X</identifier><identifier>EISSN: 1538-3636</identifier><identifier>DOI: 10.1001/archpsyc.61.12.1271</identifier><identifier>PMID: 15583118</identifier><identifier>CODEN: ARGPAQ</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Adult and adolescent clinical studies ; Benzylamines ; Biological and medical sciences ; Brain - diagnostic imaging ; Brain - metabolism ; Carbon Radioisotopes ; Depression ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - diagnostic imaging ; Depressive Disorder, Major - metabolism ; Humans ; Medical sciences ; Membrane Glycoproteins - metabolism ; Membrane Transport Proteins - metabolism ; Mood disorders ; Negativism ; Nerve Tissue Proteins - metabolism ; Positron-Emission Tomography - statistics &amp; numerical data ; Psychiatric Status Rating Scales - statistics &amp; numerical data ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Serotonin - metabolism ; Serotonin Plasma Membrane Transport Proteins</subject><ispartof>Archives of general psychiatry, 2004-12, Vol.61 (12), p.1271-1279</ispartof><rights>2005 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16344412$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15583118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MEYER, Jeffrey H</creatorcontrib><creatorcontrib>HOULE, Sylvain</creatorcontrib><creatorcontrib>SAGRATI, Sandra</creatorcontrib><creatorcontrib>CARELLA, Anna</creatorcontrib><creatorcontrib>HUSSEY, Doug F</creatorcontrib><creatorcontrib>GINOVART, Nathalie</creatorcontrib><creatorcontrib>GOULDING, Verdell</creatorcontrib><creatorcontrib>KENNEDY, James</creatorcontrib><creatorcontrib>WILSON, Alan A</creatorcontrib><title>Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes</title><title>Archives of general psychiatry</title><addtitle>Arch Gen Psychiatry</addtitle><description>Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin. Regional 5-HTT BP was measured in 20 nonsmoking medication-free (&gt; or =3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale. No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F(1,26), 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to &lt;.001]). Serotonin transporters play an important role during depression. The magnitude of regional 5-HTT BP can provide a vulnerability to low levels of extracellular serotonin and symptoms of extremely negativistic dysfunctional attitudes.</description><subject>Adult and adolescent clinical studies</subject><subject>Benzylamines</subject><subject>Biological and medical sciences</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Carbon Radioisotopes</subject><subject>Depression</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - diagnostic imaging</subject><subject>Depressive Disorder, Major - metabolism</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Membrane Transport Proteins - metabolism</subject><subject>Mood disorders</subject><subject>Negativism</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Positron-Emission Tomography - statistics &amp; numerical data</subject><subject>Psychiatric Status Rating Scales - statistics &amp; numerical data</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Serotonin - metabolism</subject><subject>Serotonin Plasma Membrane Transport Proteins</subject><issn>0003-990X</issn><issn>1538-3636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0MFu1DAQAFALgehS-AIk5Au9ZfHEiZNwa0uBSpV6aJG4rSb2pOsqsYPttMrH8W94xSIsSx57nkbjYew9iC0IAZ8w6P0cV71VsIUy7wZesA3Usi2kkuol2wghZNF14ucJexPjY76KWpWv2QnUdSsB2g37fRHQOn5HwSfvcpQCujj7kCjw3jpj3QOffSKXLI58IoxLIMOfbdpzjaH3jgMUI_Y05ucv53cXmUebQk7QZGO0OUh-8g8B5_36mV8NA-kUuR_4hI8-cENzoOyeiNNsozcUOTrDIz1RsGk9SLPGYXE65WK5C0zJpiW7t-zVgGOkd8fzlP34enV_-b24uf12fXl-U8xQV6lA3VLZi4EEqK7XTaXrQRsUiC0Z0rLRdaNJVKAaQ12nalEKlROHZUoQ8pSd_a07B_9roZh2-WeaxhEd-SXuVANV24oD_HCESz-R2c3BThjW3b-BZ_DxCDBqHIc8bW3jf6dkVVVQyj9CmJh3</recordid><startdate>200412</startdate><enddate>200412</enddate><creator>MEYER, Jeffrey H</creator><creator>HOULE, Sylvain</creator><creator>SAGRATI, Sandra</creator><creator>CARELLA, Anna</creator><creator>HUSSEY, Doug F</creator><creator>GINOVART, Nathalie</creator><creator>GOULDING, Verdell</creator><creator>KENNEDY, James</creator><creator>WILSON, Alan A</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200412</creationdate><title>Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes</title><author>MEYER, Jeffrey H ; HOULE, Sylvain ; SAGRATI, Sandra ; CARELLA, Anna ; HUSSEY, Doug F ; GINOVART, Nathalie ; GOULDING, Verdell ; KENNEDY, James ; WILSON, Alan A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p154t-ac8e2b0fe0169bc74c5fcda0aa8edec37c57ce04167de99650206decccccd2103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Benzylamines</topic><topic>Biological and medical sciences</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Carbon Radioisotopes</topic><topic>Depression</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - diagnostic imaging</topic><topic>Depressive Disorder, Major - metabolism</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Membrane Transport Proteins - metabolism</topic><topic>Mood disorders</topic><topic>Negativism</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Positron-Emission Tomography - statistics &amp; numerical data</topic><topic>Psychiatric Status Rating Scales - statistics &amp; numerical data</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Serotonin - metabolism</topic><topic>Serotonin Plasma Membrane Transport Proteins</topic><toplevel>online_resources</toplevel><creatorcontrib>MEYER, Jeffrey H</creatorcontrib><creatorcontrib>HOULE, Sylvain</creatorcontrib><creatorcontrib>SAGRATI, Sandra</creatorcontrib><creatorcontrib>CARELLA, Anna</creatorcontrib><creatorcontrib>HUSSEY, Doug F</creatorcontrib><creatorcontrib>GINOVART, Nathalie</creatorcontrib><creatorcontrib>GOULDING, Verdell</creatorcontrib><creatorcontrib>KENNEDY, James</creatorcontrib><creatorcontrib>WILSON, Alan A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of general psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MEYER, Jeffrey H</au><au>HOULE, Sylvain</au><au>SAGRATI, Sandra</au><au>CARELLA, Anna</au><au>HUSSEY, Doug F</au><au>GINOVART, Nathalie</au><au>GOULDING, Verdell</au><au>KENNEDY, James</au><au>WILSON, Alan A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes</atitle><jtitle>Archives of general psychiatry</jtitle><addtitle>Arch Gen Psychiatry</addtitle><date>2004-12</date><risdate>2004</risdate><volume>61</volume><issue>12</issue><spage>1271</spage><epage>1279</epage><pages>1271-1279</pages><issn>0003-990X</issn><eissn>1538-3636</eissn><coden>ARGPAQ</coden><abstract>Although brain serotonin transporter (5-HTT) density has been investigated in subjects with a history of major depressive episodes (MDE), there has never been an investigation of brain 5-HTT during a current MDE. Brain 5-HTT binding potential (BP) may have an important role during MDE due to major depressive disorder, because the 5-HTT regulates extracellular 5-HT. The BP is an index of receptor density. Carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB) positron emission tomography (PET) is the first brain imaging technique that can measure the 5-HTT BP in cortical and subcortical brain regions in vivo. The purposes of this study were to investigate 5-HTT BP during MDE and to determine the relationship between 5-HTT BP and negativistic dysfunctional attitudes during MDE. Dysfunctional attitudes are negatively biased assumptions and beliefs regarding oneself, the world, and the future. Our recent publication of increased serotonin2 BP in MDE with severely negativistic dysfunctional attitudes suggests that this subgroup of MDE subjects has very low levels of extracellular serotonin. Regional 5-HTT BP was measured in 20 nonsmoking medication-free (&gt; or =3 months) depressed subjects and 20 age-matched nonsmoking, medication-free, healthy subjects using [11C]DASB PET. Dysfunctional attitudes were measured using the Dysfunctional Attitudes Scale. No difference in regional 5-HTT BP was found between MDE and healthy subjects; however, the subgroup of MDE subjects with highly negativistic dysfunctional attitudes had significantly higher 5-HTT BP compared with healthy subjects in brain regions mainly sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, bilateral caudate, and bilateral putamen; average, 21% greater; F(1,26), 5.6-12.2 [P values, .03-.002]). In the MDE subjects, increased 5-HTT BP was strongly associated with more negativistic dysfunctional attitudes in brain regions primarily sampling serotonergic nerve terminals (prefrontal cortex, anterior cingulate, thalamus, caudate, and putamen; r = 0.64-0.74 [P values, .003 to &lt;.001]). Serotonin transporters play an important role during depression. The magnitude of regional 5-HTT BP can provide a vulnerability to low levels of extracellular serotonin and symptoms of extremely negativistic dysfunctional attitudes.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>15583118</pmid><doi>10.1001/archpsyc.61.12.1271</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-990X
ispartof Archives of general psychiatry, 2004-12, Vol.61 (12), p.1271-1279
issn 0003-990X
1538-3636
language eng
recordid cdi_proquest_miscellaneous_67148800
source MEDLINE; American Medical Association Journals
subjects Adult and adolescent clinical studies
Benzylamines
Biological and medical sciences
Brain - diagnostic imaging
Brain - metabolism
Carbon Radioisotopes
Depression
Depressive Disorder, Major - diagnosis
Depressive Disorder, Major - diagnostic imaging
Depressive Disorder, Major - metabolism
Humans
Medical sciences
Membrane Glycoproteins - metabolism
Membrane Transport Proteins - metabolism
Mood disorders
Negativism
Nerve Tissue Proteins - metabolism
Positron-Emission Tomography - statistics & numerical data
Psychiatric Status Rating Scales - statistics & numerical data
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Serotonin - metabolism
Serotonin Plasma Membrane Transport Proteins
title Brain Serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A16%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brain%20Serotonin%20transporter%20binding%20potential%20measured%20with%20carbon%2011-labeled%20DASB%20positron%20emission%20tomography:%20Effects%20of%20major%20depressive%20episodes%20and%20severity%20of%20dysfunctional%20attitudes&rft.jtitle=Archives%20of%20general%20psychiatry&rft.au=MEYER,%20Jeffrey%20H&rft.date=2004-12&rft.volume=61&rft.issue=12&rft.spage=1271&rft.epage=1279&rft.pages=1271-1279&rft.issn=0003-990X&rft.eissn=1538-3636&rft.coden=ARGPAQ&rft_id=info:doi/10.1001/archpsyc.61.12.1271&rft_dat=%3Cproquest_pubme%3E67148800%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67148800&rft_id=info:pmid/15583118&rfr_iscdi=true